Home » Reports » Dechra Pharmaceuticals plc 6.6% Potential Decrease Indicated by RBC Capital Markets

Dechra Pharmaceuticals plc 6.6% Potential Decrease Indicated by RBC Capital Markets

Dechra Pharmaceuticals plc using EPIC/TICKER code (LON:DPH) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘SECTOR PERFORMER’ this morning by analysts at RBC Capital Markets. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. RBC Capital Markets have set a target price of 2510 GBX on its stock. This is indicating the analyst believes there is a potential downside of -6.6% from the opening price of 2688 GBX. Over the last 30 and 90 trading days the company share price has decreased 148 points and decreased 122 points respectively. The 1 year high stock price is 3090 GBX while the year low stock price is currently 2030 GBX.

Dechra Pharmaceuticals plc has a 50 day moving average of 2,722.39 GBX and a 200 day moving average of 2,782.31. There are currently 102,878,460 shares in issue with the average daily volume traded being 285,086. Market capitalisation for LON:DPH is £2,767,430,574 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn